Switching from one infliximab biosimilar (CT-P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis. [electronic resource]
Producer: 20210514Description: 397-398 p. digitalISSN:- 1365-2133
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.